跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,713 条关于
“Alentis”
全部
1,713
临床试验
1,503
药物
98
机构
37
资讯
75
去年
Lixudebart Shows Promise in Reversing Organ Fibrosis in Phase 2 Trials
去年
Alentis' CLDN1-Targeting ADC, ALE.P02, Receives FDA Fast Track for Advanced Squamous Cancers
3年前
Alentis Therapeutics Reports Positive Topline Results from Phase 1 Multiple Ascending Dose Cohorts Study
去年
FDA Grants Fast Track Designation to Alentis Therapeutics' ALE.P02 for CLDN1+ Squamous Solid Tumors
去年
FDA Grants Fast Track Designation to Alentis Therapeutics' ALE.P02 for CLDN1+ Squamous Cancers
去年
FDA Grants Fast Track Designation to Alentis Therapeutics' ALE.P02 for CLDN1-Positive Solid Tumors
去年
ALE.P02 Receives FDA Fast Track Designation for CLDN1-Positive Solid Tumors
去年
Frazier Healthcare Partners Closes $1.3 Billion Fund for Early-Stage Biotech Investments
3个月前
Swiss Biotech Startups Take Center Stage at Boston Roadshow as US Investors Signal Selective Recovery in 2026
5个月前
Adcendo Secures $75 Million Series C to Advance First-in-Class ADC Pipeline for High Unmet Need Cancers
第 1 页,共 8 页
上一页
下一页